ZA894181B - Amblyommin,a new active substance for anticoagulant therapy - Google Patents

Amblyommin,a new active substance for anticoagulant therapy

Info

Publication number
ZA894181B
ZA894181B ZA894181A ZA894181A ZA894181B ZA 894181 B ZA894181 B ZA 894181B ZA 894181 A ZA894181 A ZA 894181A ZA 894181 A ZA894181 A ZA 894181A ZA 894181 B ZA894181 B ZA 894181B
Authority
ZA
South Africa
Prior art keywords
ile
glu
leu
gly
ser
Prior art date
Application number
ZA894181A
Other languages
English (en)
Inventor
Werner Bonin
Paul Habermann
Dominique Tripier
Elisabet Woehner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA894181B publication Critical patent/ZA894181B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA894181A 1988-06-04 1989-06-02 Amblyommin,a new active substance for anticoagulant therapy ZA894181B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3819078A DE3819078A1 (de) 1988-06-04 1988-06-04 Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie

Publications (1)

Publication Number Publication Date
ZA894181B true ZA894181B (en) 1990-02-28

Family

ID=6355878

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894181A ZA894181B (en) 1988-06-04 1989-06-02 Amblyommin,a new active substance for anticoagulant therapy

Country Status (18)

Country Link
US (1) US5093322A (xx)
EP (1) EP0345614B1 (xx)
JP (1) JP2703993B2 (xx)
KR (1) KR0138531B1 (xx)
AT (1) ATE107666T1 (xx)
AU (1) AU618364B2 (xx)
CA (1) CA1339189C (xx)
DE (2) DE3819078A1 (xx)
DK (1) DK270489A (xx)
ES (1) ES2056149T3 (xx)
FI (1) FI93697C (xx)
HU (2) HU205148B (xx)
IE (1) IE64674B1 (xx)
IL (1) IL90508A (xx)
NO (1) NO175900C (xx)
NZ (1) NZ229401A (xx)
PT (1) PT90739B (xx)
ZA (1) ZA894181B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385885A (en) * 1988-01-15 1995-01-31 Gasic; Gregory P. Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide
DE3931839A1 (de) * 1989-09-23 1991-04-04 Basf Ag Neue proteine und ihre herstellung
DE4136513A1 (de) * 1991-11-06 1993-05-13 Basf Ag Neues thrombininhibitorisches protein aus raubwanzen
US5321010A (en) * 1991-12-10 1994-06-14 Merck & Co., Inc. Proteins for inhibiting adhesion of platelets to collagen
CA2150909A1 (en) * 1992-12-04 1994-06-23 Christiane Noeske-Jungblut Clotting inhibitor made from protostomia saliva
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US20050033022A1 (en) * 1997-09-26 2005-02-10 Smithkline Beecham Biologicals Sa Fusion proteins comprising HIV-1 Tat and/or Nef proteins
BRPI0406057B1 (pt) * 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
RU2740185C2 (ru) 2015-12-10 2021-01-12 Меникон Ко., Лтд. Пептидная композиция

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
IL83912A (en) * 1986-09-18 1993-05-13 Pennsylvania Hospital Protein having anticoagulant and antimetastatic properties
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
CA2024697A1 (en) * 1989-09-07 1991-03-08 George P. Vlasuk Protein having anticoagulant properties

Also Published As

Publication number Publication date
AU618364B2 (en) 1991-12-19
FI892690A (fi) 1989-12-05
HUT52117A (en) 1990-06-28
KR910001040A (ko) 1991-01-30
CA1339189C (en) 1997-07-29
EP0345614A2 (de) 1989-12-13
DK270489D0 (da) 1989-06-02
FI93697C (fi) 1995-05-26
NO892266L (no) 1989-12-05
DK270489A (da) 1989-12-05
HU205148B (en) 1992-03-30
PT90739B (pt) 1994-10-31
NO175900B (no) 1994-09-19
PT90739A (pt) 1989-12-29
NZ229401A (en) 1991-10-25
JPH0232100A (ja) 1990-02-01
IE891814L (en) 1989-12-04
NO892266D0 (no) 1989-06-02
NO175900C (no) 1994-12-28
AU3595489A (en) 1989-12-07
IL90508A (en) 1994-12-29
DE3819078A1 (de) 1989-12-07
FI93697B (fi) 1995-02-15
IE64674B1 (en) 1995-08-23
US5093322A (en) 1992-03-03
DE58907930D1 (de) 1994-07-28
KR0138531B1 (ko) 1998-04-30
JP2703993B2 (ja) 1998-01-26
IL90508A0 (en) 1990-01-18
EP0345614A3 (en) 1990-10-10
ES2056149T3 (es) 1994-10-01
HU210528A9 (en) 1995-04-28
ATE107666T1 (de) 1994-07-15
FI892690A0 (fi) 1989-06-01
EP0345614B1 (de) 1994-06-22

Similar Documents

Publication Publication Date Title
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
IL77227A (en) Recombinant methods for production of serine protease inhibitors and methods for isolation of same
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
PL302304A1 (en) Peptides of body organs protecting action, method of obtaining them and their application in therapy
IL90508A0 (en) Amblyommin,a new active substance for anticoagulant therapy
ES8701230A1 (es) Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores
HU895788D0 (en) Process for producing peptides and medical products containing them
EP0257312A3 (en) A new cartilage-derived leukocyte elastase-inhibitor
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
HU896448D0 (en) Process for the preparation of anticoagulant peptides
EP0241136A3 (en) Human class 1 heparin-binding growth factor
EP0723016A3 (en) Leukocyte activation factor
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
IT1153208B (it) Procedimento per l'estrazione di sostanze azotate, in particolare proteine e/o amminoacidi da sostanze vegetali, in particolare da sottoprodotti della lavorazione della soia